Page 114 - 2022_02-Haematologica-web

Y. Liu et al.
Swedish Research Council, the Swedish Cancer Society and the Swedish Children’s Cancer Society (to SK), the Tobias Prize awarded by the Royal Swedish Academy of Sciences financed by the Tobias Foundation, a clinical research grant from Lund
University Hospital (to SK), European Union project grants STEMEXPAND and PERSIST (to SK), a grant from The Royal Physiographic Society of Lund, Sweden (to YL), and a grant from Stiftelsen Lars Hiertas Minne (to YL).
References
1. Lipton JM, Ellis SR. Diamond-Blackfan ane- mia: diagnosis, treatment, and molecular pathogenesis. Hematol Oncol Clin North Am. 2009;23(2):261-282.
2. Ulirsch JC, Verboon JM, Kazerounian S, et al. The genetic landscape of Diamond- Blackfan anemia. Am J Hum Genet. 2018; 103(6):930-947.
3. Vlachos A, Muir E. How I treat Diamond- Blackfan anemia. Blood. 2010;116(19):3715- 3723.
4. Willig TN, Niemeyer CM, Leblanc T, et al. Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d'Hematologie et d'Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res. 1999;46(5):553-561.
5. Narla A, Vlachos A, Nathan DG. Diamond Blackfan anemia treatment: past, present, and future. Semin Hematol. 2011;48(2):117- 123.
6. Gripp KW, Curry C, Olney AH, et al. Diamond-Blackfan anemia with mandibulo- facial dystostosis is heterogeneous, including the novel DBA genes TSR2 and RPS28. Am J Med Genet A. 2014;164A(9):2240-2249.
7. Ludwig LS, Gazda HT, Eng JC, et al. Altered translation of GATA1 in Diamond-Blackfan anemia. Nat Med. 2014;20(7):748-753.
8. Sankaran VG, Ghazvinian R, Do R, et al. Exome sequencing identifies GATA1 muta- tions resulting in Diamond-Blackfan anemia. J Clin Invest. 2012;122(7):2439-2443.
9. Vlachos A, Ball S, Dahl N, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142(6):859- 876.
10. Boria I, Garelli E, Gazda HT, et al. The ribo- somal basis of Diamond-Blackfan anemia: mutation and database update. Hum Mutat. 2010;31(12):1269-1279.
11. Myers KC, Davies SM. Hematopoietic stem cell transplantation for bone marrow failure syndromes in children. Biol Blood Marrow Transplant. 2009;15(3):279-292.
12. Debnath S, Jaako P, Siva K, et al. Lentiviral vectors with cellular promoters correct ane- mia and lethal bone marrow failure in a mouse model for Diamond-Blackfan ane- mia. Mol Ther. 2017;25(8):1805-1814.
13.Flygare J, Olsson K, Richter J, Karlsson S. Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation. Exp Hematol. 2008;36(11): 1428-1435.
14. Hamaguchi I, Ooka A, Brun A, Richter J, Dahl N, Karlsson S. Gene transfer improves
erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood. 2002;100(8):2724-2731.
15. Jaako P, Flygare J, Olsson K, et al. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood. 2011;118(23):6087-6096.
16. Naldini L. Ex vivo gene transfer and correc- tion for cell-based therapies. Nat Rev Genet. 2011;12(5):301-315.
17. Anguela XM, High KA. Entering the modern era of gene therapy. Annu Rev Med. 2019;70:273-288.
18. Biffi A, Bartolomae CC, Cesana D, et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood. 2011;117(20): 5332-5339.
19. Cavazzana M, Bushman FD, Miccio A, Andre-Schmutz I, Six E. Gene therapy tar- geting haematopoietic stem cells for inherit- ed diseases: progress and challenges. Nat Rev Drug Discov. 2019;18(6):447-462.
20. Dull T, Zufferey R, Kelly M, et al. A third- generation lentivirus vector with a condi- tional packaging system. J Virol. 1998;72(11):8463-8471.
21. Moreno-Carranza B, Gentsch M, Stein S, et al. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther. 2009;16(1):111-118.
22. Jaako P, Debnath S, Olsson K, et al. Gene therapy cures the anemia and lethal bone marrow failure in a mouse model of RPS19- deficient Diamond-Blackfan anemia. Haematologica. 2014;99(12):1792-1798.
23. Flygare J, Kiefer T, Miyake K, et al. Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks ery- throid development and mimics defects seen in Diamond-Blackfan anemia. Blood. 2005;105(12):4627-4634.
24. Sherman E, Nobles C, Berry CC, et al. INSPI- IRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes. Mol Ther Methods Clin Dev. 2017;4:39-49.
25. Berry CC, Nobles C, Six E, et al. INSPIIRED: quantification and visualization tools for analyzing integration site distributions. Mol Ther Methods Clin Dev. 2017;4:17-26.
26. Chao A, Chazdon RL, Colwell RK, Shen TJ. Abundance-based similarity indices and their estimation when there are unseen species in samples. Biometrics. 2006;62(2): 361-371.
27. Haemmerle R, Phaltane R, Rothe M, et al. Clonal dominance with retroviral vector insertions near the ANGPT1 and ANGPT2 genes in a human xenotransplant mouse model. Mol Ther Nucleic Acids. 2014;3: e200.
28. DeLury BD. On the estimation of biological
populations. Biometrics. 1947;3(4):145-167. 29. Lam YW, Lamond AI, Mann M, Andersen JS. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal
proteins. Curr Biol. 2007;17(9):749-760.
30. Devlin EE, Dacosta L, Mohandas N, Elliott G, Bodine DM. A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associat- ed with Diamond-Blackfan anemia. Blood.
2010;116(15):2826-2835.
31.Cesana D, Ranzani M, Volpin M, et al.
32.
33.
34. 35.
36.
37. 38.
39.
40.
41.
42.
43.
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo. Mol Ther. 2014;22(4):774-785.
Deichmann A, Brugman MH, Bartholomae CC, et al. Insertion sites in engrafted cells cluster within a limited repertoire of genom- ic areas after gammaretroviral vector gene therapy. Mol Ther. 2011;19(11):2031-2039. Da Costa L, O'Donohue MF, van Dooijeweert B, et al. Molecular approaches to diagnose Diamond-Blackfan anemia: The EuroDBA experience. Eur J Med Genet. 2018;61(11):664-673.
High KA, Roncarolo MG. Gene therapy. N Engl J Med. 2019;381(5):455-464.
Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K, Sadelain M. Gene therapy comes of age. Science. 2018;359(6372):eaan4672. Marktel S, Scaramuzza S, Cicalese MP, et al. Intrabone hematopoietic stem cell gene ther- apy for adult and pediatric patients affected by transfusion-dependent ss-thalassemia. Nat Med. 2019;25(2):234-241.
Da Costa L, Leblanc T, Mohandas N. Diamond-Blackfan anemia. Blood. 2020;136 (11):1262-1273.
Giri N, Kang E, Tisdale JF, et al. Clinical and laboratory evidence for a trilineage haematopoietic defect in patients with refractory Diamond-Blackfan anaemia. Br J Haematol. 2000;108(1):167-175.
Casadevall N, Croisille L, Auffray I, Tchernia G, Coulombel L. Age-related alterations in erythroid and granulopoietic progenitors in Diamond-Blackfan anaemia. Br J Haematol. 1994;87(2):369-375.
Engidaye G, Melku M, Enawgaw B. Diamond Blackfan anemia: genetics, patho- genesis, diagnosis and treatment. EJIFCC. 2019;30(1):67-81.
Shi W, Vu T, Boucher D, et al. Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress. Blood. 2017;129 (18):2479- 2492.
Baumgartner C, Toifl S, Farlik M, et al. An ERK-dependent feedback mechanism pre- vents hematopoietic stem cell exhaustion. Cell Stem Cell. 2018;22(6):879-892.e6. Singh SK, Singh S, Gadomski S, et al. Id1 ablation protects hematopoietic stem cells from stress-induced exhaustion and aging. Cell Stem Cell. 2018;23(2):252-265.e8.
456
haematologica | 2022; 107(2)